pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
FATE THERAPEUTICS INC ($FATE) · news · pharmadog
← back to FATE THERAPEUTICS INC
News mentioning $FATE
22
stories
Sep 3, 26
Capricor, Replimune illustrate why FDA must listen to rare disease specialists
biospace
Sep 2, 26
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharma dive
Sep 2, 26
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
biopharma dive
Sep 1, 26
As MAHA champions nutrition, it’s ignoring the experts, dietitians say
stat
Aug 31, 26
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
fiercebiotech
Aug 21, 26
Capricor investor calls for change as company awaits decision on Duchenne candidate
biospace
Aug 21, 26
Scientists deploy Merck’s Ebola vaccine in DRC
stat
Aug 20, 26
Scribe’s early-stage IPO standout defies biotech’s derisking trend
biospace
Aug 20, 26
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
Aug 18, 26
Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss
fiercebiotech
Aug 14, 26
Capricor soars on potential FDA review extension, filing amendments
biospace
Jul 30, 26
Key Senate panel backs Trump’s picks for CDC, pandemic preparedness
stat
Jul 28, 26
FDA reminds investors about the risks of advisory panels
endpoints
Jul 28, 26
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
Jul 27, 26
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
biospace
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 15, 26
STAT+: At key hearing, Kennedy’s ouster of former CDC director looms over nominee to replace her
stat
Jul 10, 26
Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injector
endpoints
Jun 5, 26
Tiny HHS office tasked with protecting research participants’ safety is running on fumes
stat
May 13, 26
STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career
stat
May 12, 26
Supreme Court extends mifepristone deadline
stat
May 5, 26
The Type of Fat—Not the Amount—Fuels Pancreatic Cancer
onclive
